Skip to content
Preprint · OA via OpenAlex

An inflammatory transcriptomic signature in psoriasis associates with future cardiovascular events

Michael Seth Garshick, Tessa J. Barrett, MacIntosh Cornwell, Kamelia Drenkova, Jessica Garelik, Brittany Weber, Florencia Schlamp, Caron R. Rockman, Kelly V. Ruggles, Harmony R. Reynolds, Jeffrey S. Berger

Journal of the European Academy of Dermatology and Venereology · 2023 · ▲ 12 citations

Abstract

BACKGROUND: Psoriasis is an inflammatory skin disease associated with increased cardiovascular (CV) risk, whose pathogenesis is not fully known. OBJECTIVE: We identified a transcriptomic signature in psoriasis and investigated its association with prevalent and future risk of a CV event to understand the connection between psoriasis and CV disease (CVD). METHODS: Psoriasis patients (n = 37) with a history of moderate-severe skin disease without CVD and 11 matched controls underwent whole blood RNA sequencing. This transcriptomic signature in psoriasis versus controls was evaluated in two CVD cohorts: Women referred for cardiac catheterization with (n = 76) versus without (n = 97) myocardial infarction (MI), and patients with peripheral artery disease (n = 106) followed over 2.5 years for major adverse CV or limb events (MACLE). The association between genes differentially expressed in psoriasis and prevalent and incident CV events was assed. RESULTS: In psoriasis, median age was 44 (IQR; 34-51) years, 49% male and ACC/AHA ASCVD Risk Score of 1.0% (0.6-3.4) with no significant difference versus controls. The median psoriasis area and severity index score (PASI) was 4.0 (IQR 2.9-8.2) with 36% on biologic therapy. Overall, 247 whole blood genes were upregulated and 228 downregulated in psoriasis versus controls (p < 0.05), and 1302 genes positively and 1244 genes negatively correlated with PASI (p < 0.05). Seventy-three genes overlapped between psoriasis prevalence and PASI with key regulators identified as IL-6, IL-1β and interferon gamma. In the CVD cohorts, 50 of 73 genes (68%) identified in psoriasis associated with prevalent MI, and 29 (40%) with incident MACLE. Key regulator transcripts identified in psoriasis and CVD cohorts included SOCS3, BCL3, OSM, PIM2, PIM3 and STAT5A. CONCLUSIONS: A whole blood transcriptomic signature of psoriasis diagnosis and severity associated with prevalent MI and incident MACLE. These data have implications for better understanding the link between psoriasis, systemic inflammation and CVD.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1111/jdv.19049
Canonical
link ↗
Fetched
2026-10-15 MST

Cite this

APA
Garshick, M.S., Barrett, T.J., Cornwell, M., Drenkova, K., Garelik, J., Weber, B., Schlamp, F., Rockman, C.R., Ruggles, K.V., Reynolds, H.R., &amp; Berger, J.S. (2023). An inflammatory transcriptomic signature in psoriasis associates with future cardiovascular events. <em>Journal of the European Academy of Dermatology and Venereology</em>. https://doi.org/10.1111/jdv.19049
Vancouver
Garshick MS, Barrett TJ, Cornwell M, Drenkova K, Garelik J, Weber B, et al. An inflammatory transcriptomic signature in psoriasis associates with future cardiovascular events. Journal of the European Academy of Dermatology and Venereology. 2023. doi:10.1111/jdv.19049.
BibTeX
@unpublished{michael2023Aninfl, title = {An inflammatory transcriptomic signature in psoriasis associates with future cardiovascular events}, author = {Michael Seth Garshick and Tessa J. Barrett and MacIntosh Cornwell and Kamelia Drenkova and Jessica Garelik and Brittany Weber and Florencia Schlamp and Caron R. Rockman and Kelly V. Ruggles and Harmony R. Reynolds and Jeffrey S. Berger}, journal = {Journal of the European Academy of Dermatology and Venereology}, year = {2023}, doi = {10.1111/jdv.19049}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings